Merck wins in drug war with Glenmark

0
1505

On 7 October, Delhi High Court barred generics manufacturer Glenmark Pharmaceuticals from selling, distributing, marketing and exporting its anti-diabetes drugs Zita and Zitamet. The court found that Glenmark had infringed US-based Merck Sharp & Dohme’s sitagliptin patent used in its anti-diabetes drugs Januvia and Janumet.

You must be a subscriber to read this content, or you can register for free to enjoy the current issue.

你可以订阅去解锁所有内容。你也可以免费注册去浏览最新一期的内容。